GvHD biomarkers measured during treatment independently predict response to therapy and survival: A Blood and Marrow Transplant Clinical Trials Network Study

被引：0
|
作者：
Levine, J. E. [1 ]
Logan, B. [2 ]
Wu, J. [3 ]
Alousi, A. M. [4 ]
Bolanos-Meade, J. [5 ]
Ho, V. [6 ]
Weisdorf, D. J. [7 ]
Paczesny, S. [1 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI USA
[3] EMMES Corp, Rockville, MD USA
[4] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[5] Johns Hopkins Univ, Baltimore, MD USA
[6] Dana Farber Canc Inst, Boston, MA 02115 USA
[7] Univ Minnesota, Minneapolis, MN USA
来源：
BONE MARROW TRANSPLANTATION | 2011年 / 46卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S8 / S9
页数：2
相关论文
共 50 条
  • [1] Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study
    Levine, John E.
    Logan, Brent R.
    Wu, Juan
    Alousi, Amin M.
    Bolanos-Meade, Javier
    Ferrara, James L. M.
    Ho, Vincent T.
    Weisdorf, Daniel J.
    Paczesny, Sophie
    BLOOD, 2012, 119 (16) : 3854 - 3860
  • [2] Donor and recipient plasma follistatin levels are associated with acute GvHD in Blood and Marrow Transplant Clinical Trials Network 0402
    L M Turcotte
    T E DeFor
    L F Newell
    C S Cutler
    M R Verneris
    J Wu
    A Howard
    M L MacMillan
    J H Antin
    G M Vercellotti
    Ane Slungaard
    B R Blazar
    D J Weisdorf
    A Panoskaltsis-Mortari
    S G Holtan
    Bone Marrow Transplantation, 2018, 53 : 64 - 68
  • [3] Donor and recipient plasma follistatin levels are associated with acute GvHD in Blood and Marrow Transplant Clinical Trials Network 0402
    Turcotte, L. M.
    Defor, T. E.
    Newell, L. F.
    Cutler, C. S.
    Verneris, M. R.
    Wu, J.
    Howard, A.
    MacMillan, M. L.
    Antin, J. H.
    Vercellotti, G. M.
    Slungaard, Ane
    Blazar, B. R.
    Weisdorf, D. J.
    Panoskaltsis-Mortari, A.
    Holtan, S. G.
    BONE MARROW TRANSPLANTATION, 2018, 53 (01) : 64 - 68
  • [4] Blood and marrow transplant clinical trials network state of the science symposium 2007
    Ferrara, James L. M.
    Anasetti, Claudio
    Stadtmauer, Edward
    Antin, Joseph
    Wingard, John
    Lee, Stephanie
    Levine, John
    Schultz, Kirk
    Appelbaum, Frederick
    Negrin, Robert
    Giralt, Sergio
    Bredeson, Christopher
    Heslop, Helen
    Horowitz, Mary
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (11) : 1268 - 1285
  • [5] Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2014
    Appelbaum, Frederick R.
    Anasetti, Claudio
    Antin, Joseph H.
    Atkins, Harold
    Davies, Stella
    Devine, Steven
    Giralt, Sergio
    Heslop, Helen
    Laport, Ginna
    Lee, Stephanie J.
    Loganw, Brent
    Pasquini, Marcelo
    Pulsipher, Michael
    Stadtmauer, Edward
    Wingard, John R.
    Horowitz, Mary M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : 202 - 224
  • [6] Representativeness of Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Trial Participants
    Kaur, Manmeet
    Horowitz, Mary M.
    Mendizabal, Adam
    Chen, Min
    Foley, Amy
    Auletta, Jeffery J.
    Devine, Steven
    D'Souza, Anita
    TRANSPLANTATION AND CELLULAR THERAPY, 2025, 31 (01): : 49 - 57
  • [7] Blood and Marrow Transplant Clinical Trials Network (BMT CTN): Addressing unanswered questions
    Weisdorf, Daniel
    Carter, Shelly
    Confer, Dennis
    Ferrara, James
    Horowitz, Mary
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (03) : 257 - 262
  • [8] Mycophenolate Pharmacokinetics and Association with Response to Acute Graft-versus-Host Disease Treatment from the Blood and Marrow Transplant Clinical Trials Network
    Jacobson, Pamala A.
    Huang, Jiayin
    Wu, Juan
    Kim, Miae
    Logan, Brent
    Alousi, Amin
    Grimley, Michael
    Bolanos-Meade, Javier
    Ho, Vincent
    Levine, John E.
    Weisdorf, Daniel
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (03) : 421 - 429
  • [9] Guidance for Developing Phase II Cell Therapy Trial Proposals for Consideration by the Blood and Marrow Transplant Clinical Trials Network
    Horwitz, Edwin M.
    Horowitz, Mary M.
    DiFronzo, Nancy L.
    Kohn, Donald B.
    Heslop, Helen E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : 192 - 196
  • [10] Blood and Marrow Transplant Clinical Trials Network: Progress since the State of the Science Symposium 2007
    Ferrara, James L. M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : 149 - 153
12345